Characteristics of individuals who received a complete, 2-dose mpox vaccine regimen as part of the public health response to the mpox epidemic in Ontario, Canada.
Saved in:
| Title: | Characteristics of individuals who received a complete, 2-dose mpox vaccine regimen as part of the public health response to the mpox epidemic in Ontario, Canada. |
|---|---|
| Authors: | Grewal R; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Populations and Public Health, ICES, Toronto, Ontario, Canada., Lau C; Populations and Public Health, ICES, Toronto, Ontario, Canada., Kwong JC; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Populations and Public Health, ICES, Toronto, Ontario, Canada.; Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada.; Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; University Health Network, Toronto, Ontario, Canada., Burchell AN; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Populations and Public Health, ICES, Toronto, Ontario, Canada.; Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Unity Health Toronto, Toronto, Ontario, Canada., Friedman L; Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada., Navarro C; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada., Okpokoro E; International Research Centre of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria., Tan DHS; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Unity Health Toronto, Toronto, Ontario, Canada.; Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada., Zygmunt A; Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada.; Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada., Bai L; Populations and Public Health, ICES, Toronto, Ontario, Canada., Mishra S; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Populations and Public Health, ICES, Toronto, Ontario, Canada.; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Unity Health Toronto, Toronto, Ontario, Canada.; Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada., Buchan SA; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Populations and Public Health, ICES, Toronto, Ontario, Canada.; Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. |
| Corporate Authors: | Canadian Immunization Research Network (CIRN) Investigators |
| Source: | PLOS global public health [PLOS Glob Public Health] 2025 Nov 26; Vol. 5 (11), pp. e0005452. Date of Electronic Publication: 2025 Nov 26 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 9918283779606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-3375 (Electronic) Linking ISSN: 27673375 NLM ISO Abbreviation: PLOS Glob Public Health Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
